Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics and Resistance to Cisplatin of Human Neuroblastoma Cells Co-Cultivated with Immune and Stromal Cells. | Bioengineering (Basel) | 2022 | 36354566 | PubTator, text mining | PubMed |
| Altered gene expression in human brain microvascular endothelial cells in response to the infection of influenza H1N1 virus. | Anim Dis | 2022 | 36345345 | PubTator, text mining | PubMed |
| Impaired intratumoral natural killer cell function in head and neck carcinoma. | Front Immunol | 2022 | 36341402 | PubTator, text mining | PubMed |
| Role of the chemokine system in liver fibrosis: a narrative review. | Dig Med Res | 2022 | 36339901 | PubTator, text mining | PubMed |
| Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment. | Front Oncol | 2022 | 36338764 | PubTator, text mining | PubMed |
| Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood-brain barrier microvessels. | Fluids Barriers CNS | 2022 | 36333694 | PubTator, text mining | PubMed |
| Impairment of muscular endothelial cell regeneration in dermatomyositis. | Front Neurol | 2022 | 36330424 | PubTator, text mining | PubMed |
| Targeting the tumor stroma for cancer therapy. | Mol Cancer | 2022 | 36324128 | PubTator, text mining | PubMed |
| Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight-loss intervention: A pilot study. | Obesity (Silver Spring) | 2022 | 36321274 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy. | J Hepatocell Carcinoma | 2022 | 36320666 | PubTator, text mining | PubMed |
| NK cells and solid tumors: therapeutic potential and persisting obstacles. | Mol Cancer | 2022 | 36319998 | PubTator, text mining | PubMed |
| Exploration of various roles of hypoxia genes in osteosarcoma. | Sci Rep | 2022 | 36316355 | PubTator, text mining | PubMed |
| Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. | mBio | 2022 | 36314791 | PubTator, text mining | PubMed |
| Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment. | Front Oncol | 2022 | 36313639 | PubTator, text mining | PubMed |
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. | Front Immunol | 2022 | 36311770 | PubTator, text mining | PubMed |
| CXCR6 expressing T cells: Functions and role in the control of tumors. | Front Immunol | 2022 | 36311728 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
| Hsa_circ_0005529 promotes ZEB1 expression by regulating miR-873-5p and enhancing proliferation, invasion, and migration in gastric cancer cell lines. | J Clin Lab Anal | 2022 | 36305048 | PubTator, text mining | PubMed |
| Chitosan degradation products promote healing of burn wounds of rat skin. | Front Bioeng Biotechnol | 2022 | 36304900 | PubTator, text mining | PubMed |
| Impact of the host response and osteoblast lineage cells on periodontal disease. | Front Immunol | 2022 | 36304447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=47